Author Details

Barbieri, Marco, Centre fo Health Economics, University of York

  • Vol 12, No 2 (2015) - Original Articles
    Estimating the budget impact of innovative pharmacological treatments for patients with type 2 diabetes mellitus in Italy: the case of liraglutide (GLP-1).
    Abstract  PDF
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it (Read more).
Ok